comparemela.com
Latest Breaking News On - Land pharma q4 results review - Page 1 : comparemela.com
Gland Pharma shares tank 20% to hit new low; should you buy, sell or hold?
The drugmaker reported a 72 per cent YoY drop in net profit to Rs 79 crore in Q4FY23 due to a production shutdown at one of its facilities in Telangana and soft demand.
Telangana
Andhra-pradesh
India
China
Chinese
Motilal-oswal
Pashamylaram-penems
Gland-pharma
Kotak-institutional
Heparin-sodium
Gland-pharma
vimarsana © 2020. All Rights Reserved.